Cargando…
The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648374/ https://www.ncbi.nlm.nih.gov/pubmed/34883262 http://dx.doi.org/10.1016/j.jaip.2021.11.025 |
| _version_ | 1784610789481512960 |
|---|---|
| author | Rush, Cassandra Faulk, Kelly E. Bradley, Zanette Kanani Turner, Aubree Krumins, Maija Greenhawt, Matthew |
| author_facet | Rush, Cassandra Faulk, Kelly E. Bradley, Zanette Kanani Turner, Aubree Krumins, Maija Greenhawt, Matthew |
| author_sort | Rush, Cassandra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8648374 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86483742021-12-07 The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience Rush, Cassandra Faulk, Kelly E. Bradley, Zanette Kanani Turner, Aubree Krumins, Maija Greenhawt, Matthew J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2022-02 2021-12-06 /pmc/articles/PMC8648374/ /pubmed/34883262 http://dx.doi.org/10.1016/j.jaip.2021.11.025 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Clinical Communications Rush, Cassandra Faulk, Kelly E. Bradley, Zanette Kanani Turner, Aubree Krumins, Maija Greenhawt, Matthew The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience |
| title | The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience |
| title_full | The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience |
| title_fullStr | The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience |
| title_full_unstemmed | The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience |
| title_short | The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience |
| title_sort | safety of sars-cov-2 vaccines in persons with a known history of pegaspargase allergy: a single institution experience |
| topic | Clinical Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648374/ https://www.ncbi.nlm.nih.gov/pubmed/34883262 http://dx.doi.org/10.1016/j.jaip.2021.11.025 |
| work_keys_str_mv | AT rushcassandra thesafetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT faulkkellye thesafetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT bradleyzanettekanani thesafetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT turneraubree thesafetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT kruminsmaija thesafetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT greenhawtmatthew thesafetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT rushcassandra safetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT faulkkellye safetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT bradleyzanettekanani safetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT turneraubree safetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT kruminsmaija safetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience AT greenhawtmatthew safetyofsarscov2vaccinesinpersonswithaknownhistoryofpegaspargaseallergyasingleinstitutionexperience |